Connection

Dariusz Dudek to Everolimus

This is a "connection" page, showing publications Dariusz Dudek has written about Everolimus.
Connection Strength

1.046
  1. Vasomotor Response to Nitroglycerine Over 5 Years Follow-Up After Everolimus-Eluting Bioresorbable Scaffold Implantation. JACC Cardiovasc Interv. 2017 04 24; 10(8):786-795.
    View in: PubMed
    Score: 0.574
  2. Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial). EuroIntervention. 2018 01 20; 13(13):1561-1564.
    View in: PubMed
    Score: 0.151
  3. Long-term serial non-invasive multislice computed tomography angiography with functional evaluation after coronary implantation of a bioresorbable everolimus-eluting scaffold: the ABSORB cohort B MSCT substudy. Eur Heart J Cardiovasc Imaging. 2017 May 01; 18(8):870-879.
    View in: PubMed
    Score: 0.144
  4. Recurrent coronary vasospasm-induced acute coronary syndrome complicated by cardiac arrest. Int J Cardiol. 2015 Apr 01; 184:459-461.
    View in: PubMed
    Score: 0.124
  5. Scaffold and edge vascular response following implantation of everolimus-eluting bioresorbable vascular scaffold: a 3-year serial optical coherence tomography study. JACC Cardiovasc Interv. 2014 Dec; 7(12):1361-9.
    View in: PubMed
    Score: 0.030
  6. Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study. EuroIntervention. 2011 Apr; 6(9):1110-6.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.